VG Life Sciences Granted Key Composition of Matter Patent
02 mars 2015 10h04 HE
|
VG Life Sciences
SANTA BARBARA, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc., (OTCQB:VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, announced that the...
VG Life Sciences Announces Issuance of Patent Covering Treatment of Inflammatory Bowel Disease with Clip-Inducing Agent
29 janv. 2015 09h12 HE
|
VG Life Sciences
SANTA BARBARA, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent...
VGLS Q4 2014 Shareholder Update Letter
14 janv. 2015 10h13 HE
|
VG Life Sciences
SANTA BARBARA, Calif., Jan. 14, 2015 (GLOBE NEWSWIRE) -- VG Life Sciences Inc. releases a Q4 2014 Shareholder Update Letter:
January 14, 2015
Dear Shareholders,
Here at VG Life Sciences, our...
New Data Implicate Components of Adaptive Immunity in Traumatic Brain Injury
20 oct. 2014 08h07 HE
|
VG Life Sciences
SANTA BARBARA, Calif., Oct. 20, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc., (OTCQB:VGLS) a biotechnology company, announces today that one of its scientific advisors, Dr. Richard Tobin, PhD,...
VG Life Sciences Inc. Announces Upgrading to OTCQB Marketplace
16 oct. 2014 18h02 HE
|
VG Life Sciences
SANTA BARBARA, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc. (OTCQB: VGLS) is a biotechnology company focused on developing treatments for patients suffering from autoimmune and...
VG LIFE SCIENCES, INC. ANNOUNCES SEC FORM 10 REVIEW COMPLETE
14 oct. 2014 16h41 HE
|
VG Life Sciences
SANTA BARBARA, Calif., Oct. 14, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc. (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from...
VG Life Sciences' Advisor Gives Preeclampsia Presentation at American Heart Association Conference
12 sept. 2014 08h42 HE
|
VG Life Sciences
SANTA BARBARA, Calif., Sept. 12, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink:VGLS) a biotechnology company, announces that one of its scientific advisors, Dr. Brett Mitchell, PhD, will give...
VG Life Sciences Inc. Progress Update Phase I Cancer Study
04 sept. 2014 08h07 HE
|
VG Life Sciences
SANTA BARBARA, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces today an update to its physician-initiated IND phase I study to test...
VG Life Sciences, Inc. Announces Filing of Form 10 with the SEC.
23 juin 2014 16h48 HE
|
VG Life Sciences
SANTA BARBARA, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc. (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from...
Q1 2014 Shareholder Update Letter
13 mai 2014 11h13 HE
|
VG Life Sciences
SANTA BARBARA, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc. releases a Q1 2014 Shareholder Update Letter:
May 13, 2014
Dear Shareholders,
Here at VG Life Sciences, our goal...